BI Asset Management Fondsmaeglerselskab A S Has $30.58 Million Stock Holdings in Cardinal Health, Inc. $CAH

BI Asset Management Fondsmaeglerselskab A S lowered its position in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 10.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 148,793 shares of the company’s stock after selling 17,772 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S’s holdings in Cardinal Health were worth $30,577,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of CAH. Aventura Private Wealth LLC acquired a new stake in shares of Cardinal Health during the fourth quarter worth $25,000. Jones Financial Companies Lllp lifted its holdings in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares in the last quarter. JPL Wealth Management LLC acquired a new stake in shares of Cardinal Health during the third quarter worth $31,000. Turning Point Benefit Group Inc. acquired a new stake in shares of Cardinal Health during the third quarter worth $31,000. Finally, Cape Investment Advisory Inc. lifted its holdings in shares of Cardinal Health by 61.1% during the third quarter. Cape Investment Advisory Inc. now owns 211 shares of the company’s stock worth $33,000 after buying an additional 80 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on CAH shares. Robert W. Baird set a $248.00 price target on Cardinal Health in a research note on Friday, May 1st. JPMorgan Chase & Co. dropped their price target on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a research note on Monday, May 4th. Leerink Partners reaffirmed an “outperform” rating and issued a $275.00 price target on shares of Cardinal Health in a research note on Monday, March 9th. Barclays boosted their price target on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, February 24th. Finally, Wells Fargo & Company dropped their price target on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus price target of $241.80.

Get Our Latest Research Report on Cardinal Health

Cardinal Health Stock Up 2.0%

Cardinal Health stock opened at $205.79 on Friday. The stock has a market cap of $48.20 billion, a PE ratio of 31.47, a P/E/G ratio of 1.10 and a beta of 0.52. The business’s 50-day moving average price is $202.53 and its two-hundred day moving average price is $208.57. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60.

Cardinal Health (NYSE:CAHGet Free Report) last released its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the business posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, analysts expect that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 31.19%.

Cardinal Health Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Recommended Stories

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.